Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia
NCT00517712
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Acute Promyelocytic Leukemia
Interventions
DRUG:
Single agent arsenic trioxide
Sponsor
Christian Medical College, Vellore, India
Collaborators
[object Object]